rosiglitazone has been researched along with ovalbumin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Angeli, V; Capron, M; Hammad, H; Lambrecht, BN; Staels, B; Trottein, F | 1 |
| Angeli, V; de Heer, HJ; Hammad, H; Hoogsteden, HC; Lambrecht, BN; Soullié, T; Trottein, F | 1 |
| Chai, OH; Hwang, PH; Kim, JS; Lee, KS; Lee, MK; Lee, YC; Park, SJ; Song, CH; Yi, HK | 1 |
| Bonacci, JV; Fernandes, DJ; Quan, L; Stewart, AG; Taylor, CC; Ward, JE | 1 |
| Jeon, EJ; Kim, DH; Lee, SK; Park, CS; Park, YS; Yum, JH | 1 |
| Chae, HJ; Choe, YH; Kim, SR; Lee, KS; Lee, YC; Min, KH; Moon, H; Park, SJ; Yoo, WH | 1 |
| Ahn, JH; Bae, MA; Hong, JH; Hwang, ES; Min, HJ; Won, HY; Yoo, SE | 1 |
| Abduljawad, SH; El-Brairy, AI; El-Naa, MM; El-Readi, MZ; El-Refaei, MF; Nasif, WA | 1 |
| Kang, JY; Kim, YK; Kwon, SS; Lee, HY; Lee, SY; Park, CK; Rhee, CK; Yoon, HK | 1 |
| Gesek, M; Maślanka, T; Otrocka-Domagała, I; Zuśka-Prot, M | 1 |
| Che, H; Gu, Y; Jiang, T; Yao, L | 1 |
11 other study(ies) available for rosiglitazone and ovalbumin
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response.
Topics: Animals; Cell Migration Inhibition; Cell Movement; Cells, Cultured; Cytokines; Dendritic Cells; Dermatitis, Contact; Epidermis; Female; Fluorescein-5-isothiocyanate; Haptens; Immunosuppressive Agents; Langerhans Cells; Lung; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Transgenic; Ovalbumin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Thorax; Transcription Factors; Transcriptional Activation; Tumor Necrosis Factor-alpha | 2003 |
Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma.
Topics: Anilides; Animals; Asthma; Cell Movement; Cytokines; Dendritic Cells; Disease Models, Animal; Eosinophils; Inflammation; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; T-Lymphocytes; Thiazolidinediones; Transcription Factors; Vasodilator Agents | 2004 |
PPAR-gamma modulates allergic inflammation through up-regulation of PTEN.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Eosinophils; Female; Gene Expression; Gene Expression Regulation; Interleukin-13; Interleukin-4; Interleukin-5; Lung; Methacholine Chloride; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphatidylinositol 3-Kinases; Phosphorylation; Pioglitazone; PPAR gamma; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Trachea; Transfection | 2005 |
The PPARgamma ligand, rosiglitazone, reduces airways hyperresponsiveness in a murine model of allergen-induced inflammation.
Topics: Allergens; Animals; Bronchoalveolar Lavage Fluid; Bronchoconstrictor Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Goblet Cells; Guinea Pigs; Hyperplasia; In Vitro Techniques; Injections, Intraperitoneal; Ligands; Matrix Metalloproteinase 2; Methacholine Chloride; Mice; Mice, Inbred C57BL; Muscle Contraction; Ovalbumin; Pneumonia; PPAR gamma; Respiratory Hypersensitivity; Rosiglitazone; Thiazolidinediones; Time Factors; Trachea; Vasodilator Agents | 2006 |
The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis.
Topics: Animals; Disease Models, Animal; Female; Immunoglobulin E; Immunohistochemistry; Mice; Mice, Inbred BALB C; Ovalbumin; PPAR gamma; Rhinitis, Allergic, Perennial; Rosiglitazone; Thiazolidinediones | 2008 |
Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
Topics: Animals; Asthma; Disease Models, Animal; Down-Regulation; Female; Inflammation Mediators; Interleukin-17; Lung; Mice; Mice, Inbred C57BL; NF-kappa B; Ovalbumin; Pioglitazone; PPAR gamma; Recombinant Proteins; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2009 |
Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation.
Topics: Allergens; Animals; Anti-Allergic Agents; Apoptosis; CD4-Positive T-Lymphocytes; Cells, Cultured; Gene Expression Regulation; Indenes; Inflammation; Interleukin-2 Receptor alpha Subunit; Interleukin-4; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Structure; Morpholines; Ovalbumin; Respiratory Tract Diseases; Rosiglitazone; Th2 Cells; Thiazolidinediones | 2010 |
In-vivo antioxidant and anti-inflammatory activity of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonists in animal model of bronchial asthma.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Asthma; Catalase; Disease Models, Animal; Glutathione; Guinea Pigs; Immunoglobulin E; Interleukin-5; Male; Ovalbumin; PPAR gamma; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones | 2015 |
Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma.
Topics: Actins; Administration, Inhalation; Airway Remodeling; Animals; Anti-Asthmatic Agents; Asthma; Chronic Disease; Collagen; Disease Models, Animal; Female; Lung; Mice, Inbred BALB C; NF-kappa B; Ovalbumin; Pneumonia; PPAR gamma; Pulmonary Eosinophilia; Rosiglitazone; Signal Transduction; Thiazolidinediones; Toll-Like Receptor 4 | 2016 |
Beneficial effects of rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, in a mouse allergic asthma model is not associated with the recruitment or generation of Foxp3-expressing CD4
Topics: Animals; Asthma; CD4 Lymphocyte Count; Disease Models, Animal; Forkhead Transcription Factors; Gene Expression; Hypersensitivity; Mice; Mice, Inbred BALB C; Ovalbumin; PPAR gamma; Rosiglitazone; T-Lymphocytes, Regulatory; Treatment Outcome | 2019 |
Inhibition effect of PPAR-γ signaling on mast cell-mediated allergic inflammation through down-regulation of PAK1/ NF-κB activation.
Topics: Animals; Down-Regulation; Inflammation; Mast Cells; NF-kappa B; Ovalbumin; p21-Activated Kinases; PPAR gamma; Rats; Rosiglitazone | 2022 |